| Literature DB >> 36231695 |
Michael Anastario1, Olivia Ceavers1, Paula Firemoon2, Nezahualcoyotl Xiuhtecutli3, Ana Maria Rodriguez1.
Abstract
Life-history calendars (LHCs) can produce retrospective data regarding numerous events, exposures, and sequences that have occurred across participants' lifespans. In this mixed-quantitative-and-qualitative-methods study, processes of LHC administration were evaluated in two populations experiencing health disparities: foreign-born agricultural workers (n = 41) and Indigenous people who used injection drugs (IPWIDS) (n = 40). LHC administrator and participant perspectives were elicited during follow-up survey activities. In both agricultural workers and IPWIDs, over half of participants reported that the LHC made it easier to remember things about the past, and participant age was associated with cumulative experience in different domains of interest. Qualitative findings suggested that data-collector training and the development of concise interview guides are critical for improving LHC data quality. Participants described ethical themes, including utilitarian, cathartic, and reflective aspects, of LHC participation. Future iterations of the LHC may benefit from providing free-form and open-ended spaces for participants to reflect on the LHC activity following LHC administration.Entities:
Keywords: agricultural workers; ethics; life-history calendar; people who use injection drugs; testimonies
Mesh:
Substances:
Year: 2022 PMID: 36231695 PMCID: PMC9566298 DOI: 10.3390/ijerph191912397
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Duration and ease of LHC administration relative to the demographic characteristics of the participants of the two pilot studies, n = 81.
| Minutes to Complete LHC | Administrator-Assessed Ease of Administration | Participant-Assessed Ease of Administration | |||||
|---|---|---|---|---|---|---|---|
| Demographic Characteristics | N | Mean (SD) | F | Mean (SD) | F | % | Chi-Square |
| IPWIDs (n = 40) | |||||||
| Gender of participant | |||||||
| Male | 22 | 45.0 (14.6) | 0.4 | 2.8 (1.5) | 0.2 | 63.6% | 0.04 |
| Female | 18 | 48.2 (16.0) | 3.1 (2.9) | 66.7% | |||
| Tribal recognition status | |||||||
| Associated tribal member | 5 | 51.8 (20.4) | 0.7 | 2.4 (1.1) | 0.4 | 40.0% | 1.6 |
| Registered member of a federally recognized tribe | 35 | 45.7 (14.4) | 3.0 (2.3) | 68.6% | |||
| Age of participant | |||||||
| <40 years of age | 23 | 43.2 (12.6) | 2.7 | 43.2 (12.6) | 0.5 | 73.9% | 1.9 |
| ≥40 years of age | 17 | 50.9 (17.3) | 50.9 (17.3) | 52.9% | |||
| Foreign-born agricultural workers (n = 41) | |||||||
| Gender of participant | |||||||
| Male | 14 | 63.8 (21.2) | 0.3 | 5.4 (2.9) | 1.1 | 57.1% | 0.1 |
| Female | 27 | 67.3 (18.9) | 4.5 (2.7) | 51.9% | |||
| Language of participant | |||||||
| Monolingual Spanish | 25 | 61.6 (17.7) | 3.7 | 4.6 (2.9) | 2.7 | 52.0% | 0.1 |
| Bilingual | 16 | 73.3 (20.7) | 5.1 (2.6) | 56.3% | |||
| Age of participant | |||||||
| <60 years of age | 35 | 65.9 (19.1) | 0.0 | 4.7 (2.8) | 5.2 | 51.4% | 0.5 |
| ≥60 years of age | 6 | 67.5 (23.6) | 5.7 (2.8) | 66.7% | |||
| Country of origin of participant | |||||||
| Mexico | 22 | 65.5 (19.4) | 1.0 | 3.9 (2.4) | 3.1 | 63.6% | 2.7 |
| Guatemala | 18 | 68.3 (19.7) | 5.7 (2.9) | 44.4% | |||
| Honduras | 1 | 40.0 (0.0) | 8.0 (0.0) | 0.0% | |||
Human–chemical interactions documented over the lifespan relative to the demographic characteristics of the participants of the two pilot studies, n = 81.
| Total Number of Drugs Used during Lifetime | Cumulative Person-Polysubstance-Years of Use Documented | ||||
|---|---|---|---|---|---|
| Demographic Characteristics | N | Mean (SD) | F | Mean (SD) | F |
| IPWIDs (n = 40) | |||||
| Gender of participant | |||||
| Male | 22 | 6.7 (2.1) | 0.17 | 68.5 (25.5) | 0.45 |
| Female | 18 | 6.4 (2.3) | 75.1 (36.6) | ||
| Tribal recognition status | |||||
| Associated tribal member | 5 | 6.6 (2.2) | 0.14 | 57.6 (31.0) | 1.2 |
| Registered member of a federally recognized tribe | 35 | 6.2 (2.3) | 73.4 (30.6) | ||
| Age of participant | 0.06 | 15.3 | |||
| <40 years of age | 23 | 6.5 (2.1) | 57.4 (27.6) | ||
| ≥40 years of age | 17 | 6.6 (2.3) | 90.4 (24.4) | ||
|
|
| ||||
|
|
|
|
|
| |
| Foreign-born agricultural workers (n = 41) | |||||
| Gender of participant | |||||
| Male | 14 | 40.1 (17.3) | 3.0 | 59.1 (49.3) | 1.0 |
| Female | 27 | 32.3 (11.5) | 46.6 (31.5) | ||
| Language of participant | |||||
| Monolingual Spanish | 25 | 39.2 (14.9) | 6.7 | 51.6 (39.7) | 0.0 |
| Bilingual | 16 | 28.3 (9.8) | 49.8 (37.3) | ||
| Age of participant | |||||
| <60 years of age | 35 | 31.3 (11.6) | 27.3 | 45.9 (32.5) | 4.5 |
| ≥60 years of age | 6 | 56.5 (4.4) | 80.2 (58.2) | ||
| Country of origin of participant | |||||
| Mexico | 22 | 38.5 (13.6) | 3.6 | 40.1 (25.8) | 10.7 |
| Guatemala | 18 | 29.4 (12.7) | 56.7 (37.3) | ||
| Honduras | 1 | 56.0 (0.0) | 185.0 (0.0) | ||
Substances reported by modality of LHC administration (paper versus electronic) in a sample of Indigenous people who used injection drugs, n = 40.
| Paper-Based LHC (n = 20) | Electronic LHC (n = 20) | |||||||
|---|---|---|---|---|---|---|---|---|
| Substance | No. Detected | Years of Reported Use a | No. Detected | Years of Reported Use a | Chi-Square Test | Wilcoxon Rank-Sum |Z| | ||
| N (%) | Mean | SD | N (%) | Mean | (SD) | |||
|
| ||||||||
| Alcohol | 20 (100%) | 20.7 | 10.0 | 20 (100%) | 21.7 | 9.2 | 0.00 | 0.64 |
| Sedatives/hypnotics/tranquilizers | 4 (20%) | 1.0 | 3.0 | 5 (25%) | 0.8 | 2.4 | 0.14 | 0.26 |
| Barbiturates | 0 (0%) | 0.0 | 0.0 | 1 (5%) | 0.2 | 0.7 | 1.03 | 1.00 |
|
| ||||||||
| Cocaine | 10 (50%) | 1.4 | 2.4 | 11 (55%) | 4.6 | 8.4 | 0.10 | 0.88 |
| Amphetamines | 7 (35%) | 2.9 | 6.8 | 8 (40%) | 3.3 | 7.4 | 0.11 | 0.36 |
| Methamphetamines | 19 (95%) | 14.3 | 8.7 | 19 (95%) | 14.0 | 7.8 | 0.00 | 0.11 |
|
| 10 (50%) | 1.0 | 1.4 | 10 (50%) | 1.3 | 2.2 | 0.00 | 0.24 |
|
| ||||||||
| Heroin | 6 (30%) | 0.7 | 1.3 | 7 (35%) | 0.6 | 1.0 | 0.11 | 0.16 |
| Suboxone | 11 (55%) | 1.0 | 1.6 | 6 (30%) | 0.3 | 0.5 | 2.56 | 1.82 |
| Methadone | 3 (15%) | 0.5 | 1.6 | 5 (25%) | 0.8 | 1.5 | 0.63 | 0.83 |
| Other opiates/analgesics | 15 (75%) | 5.2 | 6.0 | 13 (65%) | 2.8 | 5.4 | 0.48 | 1.28 |
|
| 9 (45%) | 1.5 | 3.1 | 5 (25%) | 0.6 | 1.2 | 1.76 | 1.34 |
|
| 18 (90%) | 19.3 | 11.2 | 20 (100%) | 23.2 | 12.1 | 2.11 | 0.92 |
Abbreviations: ASI, Addiction Severity Index; LHC, life-history calendar; CNS, central nervous system; SD, standard deviation; P, probability value. a Among participants reporting any use.